MarginsXMarginsX
Home › Markets › Health Care › SKIN

SkinHealth Systems Inc. (SKIN)

SKIN trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$15.05
-7.73% on the day
Market cap
$98.5M
Micro cap
Revenue · 2025
$300.8M
-10.0% on 2024
Net income · 2025
-$9.5M
-3.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1818093/000162828026017376/0001628280-26-017376-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSKIN on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2020
SEC CIK0001818093
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$300.8M
Net income-$9.5M
Operating income-$20.8M
Net margin-3.2%
Operating margin-6.9%
Revenue growth-10.0%
Cash$232.7M
Total assets$499.8M
P/E (computed)Net income was not positive
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$112.4M cash at September 30, 2026
Share count, 1 year
+2.6%
2025-11-03 to 2026-11-02 · -0.3% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$112.4M cash; operating cash flow $5.9M a quarter.Report 2026-09-30
Shares outstanding6,542,468 (2026-11-02); 127,503,059 a year earlier; 131,266,839 three years earlier. 1y figure adjusted for split (1-for-20 overall); 3y figure adjusted for split (1-for-20 overall).Cover page 2026-11-02
Reverse splits, 3 years1; latest 1-for-20 on 2026-10-14Source 2026-10-14
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months1 (8-K item 3.01)8-K 2026-05-12
AuditorDeloitte & Touche LLP, Los Angeles, California, United StatesPCAOB Form AP 2026-03-23
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$69.2M-$888K$11.3M$112.4M$243.0M$288.6M10-Q 2026-11-05
Q2 2026
2026-06-30
$72.1M-$2.7M$2.7M$206.1M$345.2M$290.0M10-Q 2026-08-06
Q1 2026
2026-03-31
$64.9M-$6.6M-$5.6M$204.4M$344.2M$296.1M10-Q 2026-05-07
Q4 2025
2025-12-31
$82.4M-$8.1M$15.2M$232.7M$364.4M$300.8M10-K 2026-03-12
Q3 2025
2025-09-30
$70.7M-$11.0M$9.6M$219.4M$363.4M$301.9M10-Q 2026-11-05
Q2 2025
2025-06-30
$78.2M$19.7M$9.6M$212.0M$363.1M$310.1M10-Q 2026-08-06
Q1 2025
2025-03-31
$69.6M-$10.1M$3.0M$373.0M$553.0M$322.5M10-Q 2026-05-07
Q4 2024
2024-12-31
$83.5M-$10.3M$16.5M$370.1M$552.2M$334.3M10-K 2026-03-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32023-01-13
Latest annual report10-K2026-03-12
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxy
ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
DEFA14A2026-08-12

Source: SEC EDGAR submissions feed, 442 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+3.8%
1 month+50.7%
3 months+23.6%
Year to date+1073.4%
1 year+1154.6%
From 52-week high-47.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
SKYASkyAI Inc.$2.11-9.05%$107.3M
NYXHNyxoah SA$0.8937-0.64%$89.4M
APYXApyx Medical Corporation$2.65-5.69%$111.6M
LUCDLucid Diagnostics Inc.$0.3978-11.42%$82.3M
STIMNeuronetics Inc.$1.25-10.07%$120.6M
LUNGPulmonx Corporation$2.80-2.10%$121.9M
PYPDPolyPid Ltd.$6.15-1.76%$124.9M
LNSRLENSAR Inc.$5.29+5.80%$65.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier